Literature DB >> 17380436

The TIMP-1 gene transferred through adenovirus mediation shows a suppressive effect on peritoneal metastases from gastric cancer.

Motoshi Miyagi1, Keishiro Aoyagi, Seiya Kato, Kazuo Shirouzu.   

Abstract

BACKGROUND: It has become clear in recent years that peritoneal metastasis takes place as the result of a multistep process involving attachment, invasion, proliferation, and angiogenesis. The aim of the present study was to evaluate the suppressive effect of tissue inhibitor of metalloproteinase-1 (TIMP-1) gene transfer on peritoneal dissemination.
METHODS: We established a high-potential peritoneal metastasis cell line (MKN-45P), using the gastric cancer cell line MKN-45, and developed a peritoneal metastasis model in nude mice. The TIMP-1 gene was transferred to MKN-45 or MKN-45P by adenoviral transfection, and we performed an in vitro invasion assay and an in vivo study, using the peritoneal metastasis model. The TIMP-1 transfected group was compared with a non-virus group and a Lac-Z transfected group.
RESULTS: The in vitro invasion assay showed that the number of invasive cells was significantly reduced in the TIMP-1 transfected group compared with that in the non-virus group and the Lac-Z transfected group, Moreover, the in vivo studies showed that the number and the weight of the peritoneal nodes in the TIMP-1 transfected group were significantly less than those in the Lac-Z transfected group, and less than those in the non-viral group. No bloody ascites was recognized in the TIMP-1 transfected group. The mean number of tumor vessels in the non-virus group and the Lac-Z group was significantly higher than that in the TIMP-1 group.
CONCLUSION: TIMP-1 demonstrated an inhibitory effect on angiogenesis, and may be worthwhile investigating for use as a future therapy for peritoneal dissemination.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17380436     DOI: 10.1007/s10147-006-0616-z

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  41 in total

1.  The mechanism of inhibition of collagenase by TIMP-1.

Authors:  K B Taylor; L J Windsor; N C Caterina; M K Bodden; J A Engler
Journal:  J Biol Chem       Date:  1996-09-27       Impact factor: 5.157

2.  Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer.

Authors:  Yutaka Yonemura; Yoshio Endou; Hideto Fujita; Sachio Fushida; Etsurou Bandou; Keizou Taniguchi; Kouichi Miwa; Kazuo Sugiyama; Takuma Sasaki
Journal:  Gastric Cancer       Date:  2000-09-29       Impact factor: 7.370

3.  Plasma levels of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 correlate with disease stage and survival in colorectal cancer patients.

Authors:  Erwin T Waas; Thijs Hendriks; Roger M L M Lomme; Theo Wobbes
Journal:  Dis Colon Rectum       Date:  2005-04       Impact factor: 4.585

4.  Matrix metalloproteinases and their inhibitors in gastric cancer.

Authors:  G I Murray; M E Duncan; E Arbuckle; W T Melvin; J E Fothergill
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

5.  Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells.

Authors:  Hee-Jin Kwak; Myung-Jin Park; Hyeyoung Cho; Chang-Min Park; Sang-Ik Moon; Hyung-Chan Lee; In-Chul Park; Mi-Suk Kim; Chang Hun Rhee; Seok-Il Hong
Journal:  Mol Cancer Res       Date:  2006-03       Impact factor: 5.852

6.  Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice.

Authors:  M Watanabe; Y Takahashi; T Ohta; M Mai; T Sasaki; M Seiki
Journal:  Cancer       Date:  1996-04-15       Impact factor: 6.860

7.  Inhibition of angiogenesis by tissue inhibitor of metalloproteinase.

Authors:  M D Johnson; H R Kim; L Chesler; G Tsao-Wu; N Bouck; P J Polverini
Journal:  J Cell Physiol       Date:  1994-07       Impact factor: 6.384

8.  Tissue inhibitor of metalloproteinases-1 signalling pathway leading to erythroid cell survival.

Authors:  Elise Lambert; Cédric Boudot; Zahra Kadri; Mahdhia Soula-Rothhut; Marie-Line Sowa; Patrick Mayeux; William Hornebeck; Bernard Haye; Emmanuelle Petitfrere
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

9.  Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells.

Authors:  R Khokha; M J Zimmer; C H Graham; P K Lala; P Waterhouse
Journal:  J Natl Cancer Inst       Date:  1992-07-01       Impact factor: 13.506

10.  Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro.

Authors:  C M Alexander; Z Werb
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

View more
  10 in total

1.  A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis.

Authors:  Kazuki N Sugahara; Pablo Scodeller; Gary B Braun; Tatiana Hurtado de Mendoza; Chisato M Yamazaki; Michael D Kluger; Joji Kitayama; Edwin Alvarez; Stephen B Howell; Tambet Teesalu; Erkki Ruoslahti; Andrew M Lowy
Journal:  J Control Release       Date:  2015-06-11       Impact factor: 9.776

2.  Tumor angiogenesis: insights and innovations.

Authors:  Fernando Nussenbaum; Ira M Herman
Journal:  J Oncol       Date:  2010-04-26       Impact factor: 4.375

3.  Suppressive effect of bevacizumab on peritoneal dissemination from gastric cancer in a peritoneal metastasis model.

Authors:  Takuya Imaizumi; Keishiro Aoyagi; Motoshi Miyagi; Kazuo Shirouzu
Journal:  Surg Today       Date:  2010-08-26       Impact factor: 2.549

4.  Inflammation induced by MMP-9 enhances tumor regression of experimental breast cancer.

Authors:  Karin Söderlund Leifler; Susanne Svensson; Annelie Abrahamsson; Christina Bendrik; Jennifer Robertson; Jack Gauldie; Anna-Karin Olsson; Charlotta Dabrosin
Journal:  J Immunol       Date:  2013-03-15       Impact factor: 5.422

5.  Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer.

Authors:  Keishiro Aoyagi; Kikuo Kouhuji; Motoshi Miyagi; Junya Kizaki; Taro Isobe; Kousuke Hashimoto; Kazuo Shirouzu
Journal:  World J Crit Care Med       Date:  2013-11-04

6.  Mechanisms of peritoneal dissemination in gastric cancer.

Authors:  Feng Sun; Min Feng; Wenxian Guan
Journal:  Oncol Lett       Date:  2017-10-09       Impact factor: 2.967

7.  Research and clinical applications of molecular biomarkers in gastrointestinal carcinoma (Review).

Authors:  Feng Jiao; Ziliang Jin; Lei Wang; Liwei Wang
Journal:  Biomed Rep       Date:  2013-08-20

Review 8.  Broad targeting of angiogenesis for cancer prevention and therapy.

Authors:  Zongwei Wang; Charlotta Dabrosin; Xin Yin; Mark M Fuster; Alexandra Arreola; W Kimryn Rathmell; Daniele Generali; Ganji P Nagaraju; Bassel El-Rayes; Domenico Ribatti; Yi Charlie Chen; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Somaira Nowsheen; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Bill Helferich; Xujuan Yang; Gunjan Guha; Dipita Bhakta; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Dorota Halicka; Sulma I Mohammed; Asfar S Azmi; Alan Bilsland; W Nicol Keith; Lasse D Jensen
Journal:  Semin Cancer Biol       Date:  2015-01-16       Impact factor: 15.707

9.  The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.

Authors:  Ming-Han Tsai; Xiaochen Lin; Anatoliy Shumilov; Katharina Bernhardt; Regina Feederle; Remy Poirey; Annette Kopp-Schneider; Bruno Pereira; Raquel Almeida; Henri-Jacques Delecluse
Journal:  Oncotarget       Date:  2017-02-07

10.  IL35 predicts prognosis in gastric cancer and is associated with angiogenesis by altering TIMP1, PAI1 and IGFBP1.

Authors:  Xiao Li; Nan Niu; Jing Sun; Yiping Mou; Xujun He; Linhang Mei
Journal:  FEBS Open Bio       Date:  2020-11-09       Impact factor: 2.693

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.